Tuesday

15-04-2025 Vol 19

Category: Pharma

Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solution

Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application…

ScamGame:Despite the Enforcement Directorate’s (ED) request to the Nigerian government to attach the assets of a Sterling Biotech group entity, the company is operational.

Despite the Enforcement Directorate’s (ED) request to the Nigerian government to attach the assets of a Sterling Biotech group entity,…

Alembic announces upto 50 lakhs of financial aide for deceased Employees due to Covid 19.

Alembic Pharmaceuticals Ltd has announced Financial Aid of  between  15 lakhs to 50 lakhs to their deceased employees, which is…

Jubilant Pharma wins over Bracco’s Legal appeals in the United States Court of Appeals

Jubilant Pharma Limited (“Jubilant”), a subsidiary of Jubilant Pharmova Limited, announced that it has received a favorable and unanimous judgment…

Alembic Pharmaceuticals recieves USFDA approval for Opthalmic Solution.

Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Dorzolamide Hydrochloride and…

Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores

Net Profit up 42% to Rs 1178 crores for the yearAlembic Pharmaceuticals Limited reported its consolidated financial results for the…

Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores

Net Profit up 42% to Rs 1178 crores for the yearAlembic Pharmaceuticals Limited reported its consolidated financial results for the…

PharmEasy to vaccinate 3 crore people in coming months

Amid the rising COVID-19 cases in the second wave, we wanted to contribute our bit in breaking the chain by…

PharmEasy to vaccinate 3 crore people in coming months

Amid the rising COVID-19 cases in the second wave, we wanted to contribute our bit in breaking the chain by…

Jubilant Pharma develops a novel oral formulation of Remdesivir.

Jubilant Pharma on Monday announced that it has developed a novel oral formulation of Remdesivir, which, the company said, is…